Apmonia Therapeutics
Research - Reims, Grand Est, France
Apmonia Therapeutics Employees
Apmonia Therapeutics Details
Apmonia Therapeutics SAS is a biotechnology company dedicated to developing anti-cancer immunotherapy strategies. Our innovative technological approach is to target tumors overexpressing matricellular protein thrombospondin-1 (TSP-1).Our long-term vision is to develop personalized immunotherapy approaches combining a proprietary therapeutic peptide targeting TSP-1 (namely TAX2 peptide) and a companion diagnostic kit, which may enable patient stratification for TAX2 therapy eligibility based on the monitoring of circulating TSP-1.
Website:
http://www.apmonia-therapeutics.com
Employees:
8
HQ:
Location:
Reims, Grand Est, France
Revenue:
Apmonia Therapeutics Technologies
Load Balancers
Apache
CMS
WordPress.org
Fonts
Google Font API
Other
Google Maps